nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketorolac—PTGS1—breast cancer	0.391	0.636	CbGaD
Ketorolac—PTGS2—breast cancer	0.223	0.364	CbGaD
Ketorolac—Tolmetin—CXCL8—breast cancer	0.000693	0.119	CrCbGaD
Ketorolac—Tiaprofenic acid—PTGS1—breast cancer	0.000447	0.0766	CrCbGaD
Ketorolac—Nepafenac—PTGS1—breast cancer	0.000426	0.0729	CrCbGaD
Ketorolac—Fenbufen—PTGS1—breast cancer	0.000407	0.0697	CrCbGaD
Ketorolac—Mebendazole—CYP1A1—breast cancer	0.000365	0.0625	CrCbGaD
Ketorolac—Tolmetin—PTGS1—breast cancer	0.000354	0.0606	CrCbGaD
Ketorolac—Salsalate—PTGS1—breast cancer	0.000354	0.0606	CrCbGaD
Ketorolac—Suprofen—PTGS1—breast cancer	0.000339	0.0581	CrCbGaD
Ketorolac—Ketoprofen—CXCL8—breast cancer	0.000338	0.0579	CrCbGaD
Ketorolac—Tiaprofenic acid—PTGS2—breast cancer	0.000256	0.0438	CrCbGaD
Ketorolac—Nepafenac—PTGS2—breast cancer	0.000243	0.0417	CrCbGaD
Ketorolac—Mebendazole—CYP3A4—breast cancer	0.000233	0.0399	CrCbGaD
Ketorolac—Fenbufen—PTGS2—breast cancer	0.000233	0.0399	CrCbGaD
Ketorolac—PTGS1—nipple—breast cancer	0.00021	0.0744	CbGeAlD
Ketorolac—Tolmetin—PTGS2—breast cancer	0.000202	0.0346	CrCbGaD
Ketorolac—Salsalate—PTGS2—breast cancer	0.000202	0.0346	CrCbGaD
Ketorolac—Mebendazole—ABCB1—breast cancer	0.000194	0.0332	CrCbGaD
Ketorolac—Suprofen—PTGS2—breast cancer	0.000194	0.0332	CrCbGaD
Ketorolac—Ketoprofen—PTGS1—breast cancer	0.000173	0.0296	CrCbGaD
Ketorolac—PTGS2—embryo—breast cancer	0.000166	0.0587	CbGeAlD
Ketorolac—PTGS1—epithelium—breast cancer	0.000141	0.0501	CbGeAlD
Ketorolac—PTGS2—epithelium—breast cancer	0.000135	0.0479	CbGeAlD
Ketorolac—PTGS1—skin of body—breast cancer	0.000134	0.0477	CbGeAlD
Ketorolac—PTGS2—skin of body—breast cancer	0.000128	0.0456	CbGeAlD
Ketorolac—PTGS1—endometrium—breast cancer	0.000127	0.045	CbGeAlD
Ketorolac—PTGS2—endometrium—breast cancer	0.000121	0.043	CbGeAlD
Ketorolac—PTGS1—uterus—breast cancer	0.000117	0.0414	CbGeAlD
Ketorolac—PTGS1—pituitary gland—breast cancer	0.000115	0.0407	CbGeAlD
Ketorolac—PTGS1—adipose tissue—breast cancer	0.000114	0.0405	CbGeAlD
Ketorolac—PTGS2—uterus—breast cancer	0.000112	0.0396	CbGeAlD
Ketorolac—PTGS2—pituitary gland—breast cancer	0.00011	0.0389	CbGeAlD
Ketorolac—PTGS2—adipose tissue—breast cancer	0.000109	0.0387	CbGeAlD
Ketorolac—PTGS1—female reproductive system—breast cancer	0.000105	0.0372	CbGeAlD
Ketorolac—PTGS1—adrenal gland—breast cancer	0.000102	0.0363	CbGeAlD
Ketorolac—PTGS2—female reproductive system—breast cancer	0.0001	0.0356	CbGeAlD
Ketorolac—Ketoprofen—PTGS2—breast cancer	9.86e-05	0.0169	CrCbGaD
Ketorolac—PTGS2—adrenal gland—breast cancer	9.79e-05	0.0347	CbGeAlD
Ketorolac—PTGS1—female gonad—breast cancer	9.55e-05	0.0339	CbGeAlD
Ketorolac—PTGS2—bone marrow—breast cancer	9.47e-05	0.0336	CbGeAlD
Ketorolac—PTGS2—female gonad—breast cancer	9.13e-05	0.0324	CbGeAlD
Ketorolac—PTGS1—endocrine gland—breast cancer	8.88e-05	0.0315	CbGeAlD
Ketorolac—Ketoprofen—ALB—breast cancer	8.79e-05	0.0151	CrCbGaD
Ketorolac—PTGS2—endocrine gland—breast cancer	8.49e-05	0.0301	CbGeAlD
Ketorolac—PTGS1—lymph node—breast cancer	6.14e-05	0.0218	CbGeAlD
Ketorolac—PTGS2—lymph node—breast cancer	5.87e-05	0.0208	CbGeAlD
Ketorolac—Fatigue—Docetaxel—breast cancer	3.87e-05	0.000128	CcSEcCtD
Ketorolac—Angiopathy—Epirubicin—breast cancer	3.86e-05	0.000128	CcSEcCtD
Ketorolac—Urethral disorder—Doxorubicin—breast cancer	3.86e-05	0.000128	CcSEcCtD
Ketorolac—Nausea—Mitoxantrone—breast cancer	3.85e-05	0.000128	CcSEcCtD
Ketorolac—Nausea—Irinotecan—breast cancer	3.85e-05	0.000128	CcSEcCtD
Ketorolac—Immune system disorder—Epirubicin—breast cancer	3.85e-05	0.000128	CcSEcCtD
Ketorolac—Mediastinal disorder—Epirubicin—breast cancer	3.84e-05	0.000127	CcSEcCtD
Ketorolac—Pain—Docetaxel—breast cancer	3.84e-05	0.000127	CcSEcCtD
Ketorolac—Constipation—Docetaxel—breast cancer	3.84e-05	0.000127	CcSEcCtD
Ketorolac—Back pain—Methotrexate—breast cancer	3.83e-05	0.000127	CcSEcCtD
Ketorolac—Dyspepsia—Capecitabine—breast cancer	3.82e-05	0.000127	CcSEcCtD
Ketorolac—Chills—Epirubicin—breast cancer	3.82e-05	0.000127	CcSEcCtD
Ketorolac—Arrhythmia—Epirubicin—breast cancer	3.8e-05	0.000126	CcSEcCtD
Ketorolac—Visual impairment—Doxorubicin—breast cancer	3.8e-05	0.000126	CcSEcCtD
Ketorolac—Asthenia—Paclitaxel—breast cancer	3.8e-05	0.000126	CcSEcCtD
Ketorolac—Decreased appetite—Capecitabine—breast cancer	3.78e-05	0.000125	CcSEcCtD
Ketorolac—Alopecia—Epirubicin—breast cancer	3.76e-05	0.000125	CcSEcCtD
Ketorolac—Nausea—Gemcitabine—breast cancer	3.75e-05	0.000124	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Capecitabine—breast cancer	3.75e-05	0.000124	CcSEcCtD
Ketorolac—Fatigue—Capecitabine—breast cancer	3.74e-05	0.000124	CcSEcCtD
Ketorolac—Pruritus—Paclitaxel—breast cancer	3.74e-05	0.000124	CcSEcCtD
Ketorolac—Vision blurred—Methotrexate—breast cancer	3.73e-05	0.000124	CcSEcCtD
Ketorolac—Mental disorder—Epirubicin—breast cancer	3.73e-05	0.000124	CcSEcCtD
Ketorolac—Erythema multiforme—Doxorubicin—breast cancer	3.73e-05	0.000123	CcSEcCtD
Ketorolac—Pain—Capecitabine—breast cancer	3.71e-05	0.000123	CcSEcCtD
Ketorolac—Constipation—Capecitabine—breast cancer	3.71e-05	0.000123	CcSEcCtD
Ketorolac—Malnutrition—Epirubicin—breast cancer	3.71e-05	0.000123	CcSEcCtD
Ketorolac—Erythema—Epirubicin—breast cancer	3.71e-05	0.000123	CcSEcCtD
Ketorolac—Feeling abnormal—Docetaxel—breast cancer	3.7e-05	0.000123	CcSEcCtD
Ketorolac—Nausea—Fluorouracil—breast cancer	3.69e-05	0.000122	CcSEcCtD
Ketorolac—Eye disorder—Doxorubicin—breast cancer	3.68e-05	0.000122	CcSEcCtD
Ketorolac—Ill-defined disorder—Methotrexate—breast cancer	3.68e-05	0.000122	CcSEcCtD
Ketorolac—Tinnitus—Doxorubicin—breast cancer	3.67e-05	0.000122	CcSEcCtD
Ketorolac—Gastrointestinal pain—Docetaxel—breast cancer	3.67e-05	0.000122	CcSEcCtD
Ketorolac—Anaemia—Methotrexate—breast cancer	3.66e-05	0.000121	CcSEcCtD
Ketorolac—Flushing—Doxorubicin—breast cancer	3.66e-05	0.000121	CcSEcCtD
Ketorolac—Cardiac disorder—Doxorubicin—breast cancer	3.66e-05	0.000121	CcSEcCtD
Ketorolac—Flatulence—Epirubicin—breast cancer	3.65e-05	0.000121	CcSEcCtD
Ketorolac—Tension—Epirubicin—breast cancer	3.64e-05	0.000121	CcSEcCtD
Ketorolac—Dysgeusia—Epirubicin—breast cancer	3.63e-05	0.00012	CcSEcCtD
Ketorolac—Diarrhoea—Paclitaxel—breast cancer	3.62e-05	0.00012	CcSEcCtD
Ketorolac—Nervousness—Epirubicin—breast cancer	3.6e-05	0.000119	CcSEcCtD
Ketorolac—Back pain—Epirubicin—breast cancer	3.59e-05	0.000119	CcSEcCtD
Ketorolac—Feeling abnormal—Capecitabine—breast cancer	3.58e-05	0.000119	CcSEcCtD
Ketorolac—Angiopathy—Doxorubicin—breast cancer	3.57e-05	0.000119	CcSEcCtD
Ketorolac—Malaise—Methotrexate—breast cancer	3.57e-05	0.000118	CcSEcCtD
Ketorolac—Immune system disorder—Doxorubicin—breast cancer	3.56e-05	0.000118	CcSEcCtD
Ketorolac—Vertigo—Methotrexate—breast cancer	3.56e-05	0.000118	CcSEcCtD
Ketorolac—Gastrointestinal pain—Capecitabine—breast cancer	3.55e-05	0.000118	CcSEcCtD
Ketorolac—Mediastinal disorder—Doxorubicin—breast cancer	3.55e-05	0.000118	CcSEcCtD
Ketorolac—Body temperature increased—Docetaxel—breast cancer	3.55e-05	0.000118	CcSEcCtD
Ketorolac—Abdominal pain—Docetaxel—breast cancer	3.55e-05	0.000118	CcSEcCtD
Ketorolac—Leukopenia—Methotrexate—breast cancer	3.55e-05	0.000118	CcSEcCtD
Ketorolac—Chills—Doxorubicin—breast cancer	3.54e-05	0.000117	CcSEcCtD
Ketorolac—Arrhythmia—Doxorubicin—breast cancer	3.52e-05	0.000117	CcSEcCtD
Ketorolac—Dizziness—Paclitaxel—breast cancer	3.5e-05	0.000116	CcSEcCtD
Ketorolac—Vision blurred—Epirubicin—breast cancer	3.49e-05	0.000116	CcSEcCtD
Ketorolac—Alopecia—Doxorubicin—breast cancer	3.48e-05	0.000115	CcSEcCtD
Ketorolac—Cough—Methotrexate—breast cancer	3.46e-05	0.000115	CcSEcCtD
Ketorolac—Mental disorder—Doxorubicin—breast cancer	3.45e-05	0.000114	CcSEcCtD
Ketorolac—Urticaria—Capecitabine—breast cancer	3.45e-05	0.000114	CcSEcCtD
Ketorolac—Ill-defined disorder—Epirubicin—breast cancer	3.44e-05	0.000114	CcSEcCtD
Ketorolac—Abdominal pain—Capecitabine—breast cancer	3.43e-05	0.000114	CcSEcCtD
Ketorolac—Body temperature increased—Capecitabine—breast cancer	3.43e-05	0.000114	CcSEcCtD
Ketorolac—Convulsion—Methotrexate—breast cancer	3.43e-05	0.000114	CcSEcCtD
Ketorolac—Malnutrition—Doxorubicin—breast cancer	3.43e-05	0.000114	CcSEcCtD
Ketorolac—Erythema—Doxorubicin—breast cancer	3.43e-05	0.000114	CcSEcCtD
Ketorolac—Anaemia—Epirubicin—breast cancer	3.43e-05	0.000114	CcSEcCtD
Ketorolac—Agitation—Epirubicin—breast cancer	3.41e-05	0.000113	CcSEcCtD
Ketorolac—PTGS1—Metabolism—GPX2—breast cancer	3.38e-05	0.00045	CbGpPWpGaD
Ketorolac—PTGS2—Disease—ELL—breast cancer	3.38e-05	0.00045	CbGpPWpGaD
Ketorolac—Flatulence—Doxorubicin—breast cancer	3.38e-05	0.000112	CcSEcCtD
Ketorolac—PTGS2—Metabolism—ALDH1A1—breast cancer	3.38e-05	0.00045	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ALDH7A1—breast cancer	3.38e-05	0.00045	CbGpPWpGaD
Ketorolac—Arthralgia—Methotrexate—breast cancer	3.37e-05	0.000112	CcSEcCtD
Ketorolac—Chest pain—Methotrexate—breast cancer	3.37e-05	0.000112	CcSEcCtD
Ketorolac—Myalgia—Methotrexate—breast cancer	3.37e-05	0.000112	CcSEcCtD
Ketorolac—Tension—Doxorubicin—breast cancer	3.37e-05	0.000112	CcSEcCtD
Ketorolac—Vomiting—Paclitaxel—breast cancer	3.36e-05	0.000112	CcSEcCtD
Ketorolac—Dysgeusia—Doxorubicin—breast cancer	3.36e-05	0.000111	CcSEcCtD
Ketorolac—PTGS2—Spinal Cord Injury—TP53—breast cancer	3.35e-05	0.000446	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—breast cancer	3.35e-05	0.000446	CbGpPWpGaD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	3.35e-05	0.000111	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—breast cancer	3.34e-05	0.000445	CbGpPWpGaD
Ketorolac—Malaise—Epirubicin—breast cancer	3.34e-05	0.000111	CcSEcCtD
Ketorolac—PTGS1—Metabolism—GPX4—breast cancer	3.34e-05	0.000444	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—SULT1A1—breast cancer	3.34e-05	0.000444	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	3.34e-05	0.000444	CbGpPWpGaD
Ketorolac—Rash—Paclitaxel—breast cancer	3.34e-05	0.000111	CcSEcCtD
Ketorolac—Dermatitis—Paclitaxel—breast cancer	3.33e-05	0.000111	CcSEcCtD
Ketorolac—Discomfort—Methotrexate—breast cancer	3.33e-05	0.00011	CcSEcCtD
Ketorolac—Nervousness—Doxorubicin—breast cancer	3.33e-05	0.00011	CcSEcCtD
Ketorolac—Vertigo—Epirubicin—breast cancer	3.33e-05	0.00011	CcSEcCtD
Ketorolac—Syncope—Epirubicin—breast cancer	3.32e-05	0.00011	CcSEcCtD
Ketorolac—Leukopenia—Epirubicin—breast cancer	3.32e-05	0.00011	CcSEcCtD
Ketorolac—Back pain—Doxorubicin—breast cancer	3.32e-05	0.00011	CcSEcCtD
Ketorolac—Headache—Paclitaxel—breast cancer	3.32e-05	0.00011	CcSEcCtD
Ketorolac—Hypersensitivity—Docetaxel—breast cancer	3.3e-05	0.00011	CcSEcCtD
Ketorolac—Palpitations—Epirubicin—breast cancer	3.28e-05	0.000109	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—breast cancer	3.27e-05	0.000435	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GSTA1—breast cancer	3.26e-05	0.000434	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—IDH1—breast cancer	3.26e-05	0.000434	CbGpPWpGaD
Ketorolac—Confusional state—Methotrexate—breast cancer	3.26e-05	0.000108	CcSEcCtD
Ketorolac—Loss of consciousness—Epirubicin—breast cancer	3.26e-05	0.000108	CcSEcCtD
Ketorolac—PTGS2—Metabolism—PHGDH—breast cancer	3.24e-05	0.000431	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ADSL—breast cancer	3.24e-05	0.000431	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—UMPS—breast cancer	3.24e-05	0.000431	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—FHL2—breast cancer	3.24e-05	0.000431	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—NME1—breast cancer	3.24e-05	0.000431	CbGpPWpGaD
Ketorolac—Cough—Epirubicin—breast cancer	3.23e-05	0.000107	CcSEcCtD
Ketorolac—Anaphylactic shock—Methotrexate—breast cancer	3.23e-05	0.000107	CcSEcCtD
Ketorolac—Vision blurred—Doxorubicin—breast cancer	3.23e-05	0.000107	CcSEcCtD
Ketorolac—PTGS1—Metabolism—NAT2—breast cancer	3.23e-05	0.000429	CbGpPWpGaD
Ketorolac—Asthenia—Docetaxel—breast cancer	3.22e-05	0.000107	CcSEcCtD
Ketorolac—Convulsion—Epirubicin—breast cancer	3.21e-05	0.000106	CcSEcCtD
Ketorolac—Infection—Methotrexate—breast cancer	3.21e-05	0.000106	CcSEcCtD
Ketorolac—Hypertension—Epirubicin—breast cancer	3.2e-05	0.000106	CcSEcCtD
Ketorolac—Hypersensitivity—Capecitabine—breast cancer	3.2e-05	0.000106	CcSEcCtD
Ketorolac—Ill-defined disorder—Doxorubicin—breast cancer	3.18e-05	0.000105	CcSEcCtD
Ketorolac—PTGS2—Metabolism—BRIP1—breast cancer	3.18e-05	0.000423	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—HPSE—breast cancer	3.18e-05	0.000423	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—LDHB—breast cancer	3.18e-05	0.000423	CbGpPWpGaD
Ketorolac—Pruritus—Docetaxel—breast cancer	3.17e-05	0.000105	CcSEcCtD
Ketorolac—Nervous system disorder—Methotrexate—breast cancer	3.17e-05	0.000105	CcSEcCtD
Ketorolac—Anaemia—Doxorubicin—breast cancer	3.17e-05	0.000105	CcSEcCtD
Ketorolac—PTGS2—Disease—HEY2—breast cancer	3.17e-05	0.000421	CbGpPWpGaD
Ketorolac—Thrombocytopenia—Methotrexate—breast cancer	3.17e-05	0.000105	CcSEcCtD
Ketorolac—Arthralgia—Epirubicin—breast cancer	3.16e-05	0.000105	CcSEcCtD
Ketorolac—Myalgia—Epirubicin—breast cancer	3.16e-05	0.000105	CcSEcCtD
Ketorolac—Chest pain—Epirubicin—breast cancer	3.16e-05	0.000105	CcSEcCtD
Ketorolac—Agitation—Doxorubicin—breast cancer	3.15e-05	0.000104	CcSEcCtD
Ketorolac—Anxiety—Epirubicin—breast cancer	3.15e-05	0.000104	CcSEcCtD
Ketorolac—Nausea—Paclitaxel—breast cancer	3.14e-05	0.000104	CcSEcCtD
Ketorolac—Skin disorder—Methotrexate—breast cancer	3.14e-05	0.000104	CcSEcCtD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	3.13e-05	0.000104	CcSEcCtD
Ketorolac—PTGS2—Disease—RPS6KB2—breast cancer	3.13e-05	0.000416	CbGpPWpGaD
Ketorolac—Hyperhidrosis—Methotrexate—breast cancer	3.13e-05	0.000104	CcSEcCtD
Ketorolac—Discomfort—Epirubicin—breast cancer	3.12e-05	0.000103	CcSEcCtD
Ketorolac—Asthenia—Capecitabine—breast cancer	3.12e-05	0.000103	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—breast cancer	3.1e-05	0.000413	CbGpPWpGaD
Ketorolac—Malaise—Doxorubicin—breast cancer	3.09e-05	0.000103	CcSEcCtD
Ketorolac—PTGS2—Disease—IDH1—breast cancer	3.09e-05	0.000411	CbGpPWpGaD
Ketorolac—Dry mouth—Epirubicin—breast cancer	3.09e-05	0.000102	CcSEcCtD
Ketorolac—Vertigo—Doxorubicin—breast cancer	3.08e-05	0.000102	CcSEcCtD
Ketorolac—Anorexia—Methotrexate—breast cancer	3.08e-05	0.000102	CcSEcCtD
Ketorolac—Syncope—Doxorubicin—breast cancer	3.08e-05	0.000102	CcSEcCtD
Ketorolac—Pruritus—Capecitabine—breast cancer	3.07e-05	0.000102	CcSEcCtD
Ketorolac—PTGS2—Spinal Cord Injury—IL6—breast cancer	3.07e-05	0.000409	CbGpPWpGaD
Ketorolac—Leukopenia—Doxorubicin—breast cancer	3.07e-05	0.000102	CcSEcCtD
Ketorolac—Diarrhoea—Docetaxel—breast cancer	3.07e-05	0.000102	CcSEcCtD
Ketorolac—Confusional state—Epirubicin—breast cancer	3.05e-05	0.000101	CcSEcCtD
Ketorolac—Palpitations—Doxorubicin—breast cancer	3.03e-05	0.0001	CcSEcCtD
Ketorolac—Oedema—Epirubicin—breast cancer	3.03e-05	0.0001	CcSEcCtD
Ketorolac—Anaphylactic shock—Epirubicin—breast cancer	3.03e-05	0.0001	CcSEcCtD
Ketorolac—Hypotension—Methotrexate—breast cancer	3.02e-05	0.0001	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—breast cancer	3.02e-05	0.000402	CbGpPWpGaD
Ketorolac—Loss of consciousness—Doxorubicin—breast cancer	3.01e-05	9.99e-05	CcSEcCtD
Ketorolac—PTGS2—Metabolism—ABCC1—breast cancer	3.01e-05	0.000401	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—HMMR—breast cancer	3.01e-05	0.000401	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GSTA3—breast cancer	3.01e-05	0.000401	CbGpPWpGaD
Ketorolac—Infection—Epirubicin—breast cancer	3.01e-05	9.96e-05	CcSEcCtD
Ketorolac—Cough—Doxorubicin—breast cancer	2.99e-05	9.92e-05	CcSEcCtD
Ketorolac—Shock—Epirubicin—breast cancer	2.98e-05	9.87e-05	CcSEcCtD
Ketorolac—Convulsion—Doxorubicin—breast cancer	2.97e-05	9.85e-05	CcSEcCtD
Ketorolac—Diarrhoea—Capecitabine—breast cancer	2.97e-05	9.85e-05	CcSEcCtD
Ketorolac—Nervous system disorder—Epirubicin—breast cancer	2.97e-05	9.83e-05	CcSEcCtD
Ketorolac—Dizziness—Docetaxel—breast cancer	2.97e-05	9.83e-05	CcSEcCtD
Ketorolac—Thrombocytopenia—Epirubicin—breast cancer	2.96e-05	9.82e-05	CcSEcCtD
Ketorolac—PTGS2—Disease—TLE3—breast cancer	2.96e-05	0.000394	CbGpPWpGaD
Ketorolac—Hypertension—Doxorubicin—breast cancer	2.96e-05	9.82e-05	CcSEcCtD
Ketorolac—Tachycardia—Epirubicin—breast cancer	2.95e-05	9.79e-05	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Methotrexate—breast cancer	2.95e-05	9.76e-05	CcSEcCtD
Ketorolac—Skin disorder—Epirubicin—breast cancer	2.94e-05	9.74e-05	CcSEcCtD
Ketorolac—PTGS2—Disease—HEY1—breast cancer	2.93e-05	0.00039	CbGpPWpGaD
Ketorolac—Hyperhidrosis—Epirubicin—breast cancer	2.92e-05	9.69e-05	CcSEcCtD
Ketorolac—Insomnia—Methotrexate—breast cancer	2.92e-05	9.69e-05	CcSEcCtD
Ketorolac—Myalgia—Doxorubicin—breast cancer	2.92e-05	9.68e-05	CcSEcCtD
Ketorolac—Chest pain—Doxorubicin—breast cancer	2.92e-05	9.68e-05	CcSEcCtD
Ketorolac—Arthralgia—Doxorubicin—breast cancer	2.92e-05	9.68e-05	CcSEcCtD
Ketorolac—PTGS2—Metabolism—PPARGC1B—breast cancer	2.92e-05	0.000388	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—CAV1—breast cancer	2.92e-05	0.000388	CbGpPWpGaD
Ketorolac—Anxiety—Doxorubicin—breast cancer	2.91e-05	9.65e-05	CcSEcCtD
Ketorolac—Paraesthesia—Methotrexate—breast cancer	2.9e-05	9.62e-05	CcSEcCtD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	2.9e-05	9.61e-05	CcSEcCtD
Ketorolac—Discomfort—Doxorubicin—breast cancer	2.89e-05	9.56e-05	CcSEcCtD
Ketorolac—Anorexia—Epirubicin—breast cancer	2.88e-05	9.56e-05	CcSEcCtD
Ketorolac—Dyspnoea—Methotrexate—breast cancer	2.88e-05	9.55e-05	CcSEcCtD
Ketorolac—PTGS2—Disease—DLL1—breast cancer	2.88e-05	0.000382	CbGpPWpGaD
Ketorolac—PTGS2—Disease—RPL23A—breast cancer	2.88e-05	0.000382	CbGpPWpGaD
Ketorolac—Somnolence—Methotrexate—breast cancer	2.87e-05	9.53e-05	CcSEcCtD
Ketorolac—Dizziness—Capecitabine—breast cancer	2.87e-05	9.52e-05	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—breast cancer	2.86e-05	0.00038	CbGpPWpGaD
Ketorolac—Dry mouth—Doxorubicin—breast cancer	2.86e-05	9.47e-05	CcSEcCtD
Ketorolac—Vomiting—Docetaxel—breast cancer	2.85e-05	9.45e-05	CcSEcCtD
Ketorolac—Dyspepsia—Methotrexate—breast cancer	2.85e-05	9.43e-05	CcSEcCtD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	2.84e-05	0.000378	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	2.84e-05	0.000378	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—DPYD—breast cancer	2.83e-05	0.000376	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—MED12—breast cancer	2.83e-05	0.000376	CbGpPWpGaD
Ketorolac—Rash—Docetaxel—breast cancer	2.83e-05	9.37e-05	CcSEcCtD
Ketorolac—Hypotension—Epirubicin—breast cancer	2.83e-05	9.37e-05	CcSEcCtD
Ketorolac—Dermatitis—Docetaxel—breast cancer	2.83e-05	9.37e-05	CcSEcCtD
Ketorolac—Confusional state—Doxorubicin—breast cancer	2.82e-05	9.36e-05	CcSEcCtD
Ketorolac—PTGS2—Disease—HIST1H2BC—breast cancer	2.82e-05	0.000375	CbGpPWpGaD
Ketorolac—PTGS2—Disease—HIST1H2BK—breast cancer	2.82e-05	0.000375	CbGpPWpGaD
Ketorolac—PTGS2—Disease—MAP2K7—breast cancer	2.82e-05	0.000375	CbGpPWpGaD
Ketorolac—Decreased appetite—Methotrexate—breast cancer	2.81e-05	9.32e-05	CcSEcCtD
Ketorolac—Headache—Docetaxel—breast cancer	2.81e-05	9.31e-05	CcSEcCtD
Ketorolac—Oedema—Doxorubicin—breast cancer	2.8e-05	9.28e-05	CcSEcCtD
Ketorolac—Anaphylactic shock—Doxorubicin—breast cancer	2.8e-05	9.28e-05	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Methotrexate—breast cancer	2.79e-05	9.25e-05	CcSEcCtD
Ketorolac—Fatigue—Methotrexate—breast cancer	2.79e-05	9.24e-05	CcSEcCtD
Ketorolac—PTGS1—Metabolism—ALDOA—breast cancer	2.78e-05	0.00037	CbGpPWpGaD
Ketorolac—Infection—Doxorubicin—breast cancer	2.78e-05	9.22e-05	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—breast cancer	2.78e-05	0.00037	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—breast cancer	2.77e-05	0.000369	CbGpPWpGaD
Ketorolac—Pain—Methotrexate—breast cancer	2.76e-05	9.16e-05	CcSEcCtD
Ketorolac—Vomiting—Capecitabine—breast cancer	2.76e-05	9.15e-05	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Epirubicin—breast cancer	2.76e-05	9.14e-05	CcSEcCtD
Ketorolac—PTGS2—Metabolism—CA9—breast cancer	2.75e-05	0.000366	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GSTA4—breast cancer	2.75e-05	0.000366	CbGpPWpGaD
Ketorolac—Shock—Doxorubicin—breast cancer	2.75e-05	9.13e-05	CcSEcCtD
Ketorolac—Nervous system disorder—Doxorubicin—breast cancer	2.75e-05	9.1e-05	CcSEcCtD
Ketorolac—Thrombocytopenia—Doxorubicin—breast cancer	2.74e-05	9.09e-05	CcSEcCtD
Ketorolac—Rash—Capecitabine—breast cancer	2.74e-05	9.08e-05	CcSEcCtD
Ketorolac—Insomnia—Epirubicin—breast cancer	2.74e-05	9.07e-05	CcSEcCtD
Ketorolac—Dermatitis—Capecitabine—breast cancer	2.74e-05	9.07e-05	CcSEcCtD
Ketorolac—Tachycardia—Doxorubicin—breast cancer	2.73e-05	9.06e-05	CcSEcCtD
Ketorolac—Headache—Capecitabine—breast cancer	2.72e-05	9.02e-05	CcSEcCtD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—GPX1—breast cancer	2.72e-05	0.000362	CbGpPWpGaD
Ketorolac—Skin disorder—Doxorubicin—breast cancer	2.72e-05	9.01e-05	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—breast cancer	2.72e-05	0.000362	CbGpPWpGaD
Ketorolac—Paraesthesia—Epirubicin—breast cancer	2.72e-05	9.01e-05	CcSEcCtD
Ketorolac—Hyperhidrosis—Doxorubicin—breast cancer	2.71e-05	8.97e-05	CcSEcCtD
Ketorolac—PTGS1—Metabolism—NCOA3—breast cancer	2.7e-05	0.00036	CbGpPWpGaD
Ketorolac—Dyspnoea—Epirubicin—breast cancer	2.7e-05	8.94e-05	CcSEcCtD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	2.69e-05	0.000358	CbGpPWpGaD
Ketorolac—Somnolence—Epirubicin—breast cancer	2.69e-05	8.92e-05	CcSEcCtD
Ketorolac—PTGS2—Metabolism—GSTA2—breast cancer	2.68e-05	0.000357	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GPX2—breast cancer	2.68e-05	0.000357	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—SLC2A2—breast cancer	2.68e-05	0.000357	CbGpPWpGaD
Ketorolac—PTGS2—Disease—RPS8—breast cancer	2.68e-05	0.000357	CbGpPWpGaD
Ketorolac—PTGS2—Disease—RPS7—breast cancer	2.68e-05	0.000357	CbGpPWpGaD
Ketorolac—Anorexia—Doxorubicin—breast cancer	2.67e-05	8.85e-05	CcSEcCtD
Ketorolac—Nausea—Docetaxel—breast cancer	2.66e-05	8.83e-05	CcSEcCtD
Ketorolac—Feeling abnormal—Methotrexate—breast cancer	2.66e-05	8.83e-05	CcSEcCtD
Ketorolac—Dyspepsia—Epirubicin—breast cancer	2.66e-05	8.83e-05	CcSEcCtD
Ketorolac—PTGS2—Disease—DKK1—breast cancer	2.66e-05	0.000354	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	2.66e-05	0.000353	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GPX4—breast cancer	2.65e-05	0.000353	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—SULT1A1—breast cancer	2.65e-05	0.000353	CbGpPWpGaD
Ketorolac—Gastrointestinal pain—Methotrexate—breast cancer	2.64e-05	8.76e-05	CcSEcCtD
Ketorolac—PTGS2—Disease—ALDOA—breast cancer	2.64e-05	0.000351	CbGpPWpGaD
Ketorolac—Decreased appetite—Epirubicin—breast cancer	2.63e-05	8.72e-05	CcSEcCtD
Ketorolac—PTGS1—Metabolism—ABCG2—breast cancer	2.63e-05	0.00035	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CPT1A—breast cancer	2.63e-05	0.00035	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—MTR—breast cancer	2.63e-05	0.00035	CbGpPWpGaD
Ketorolac—Hypotension—Doxorubicin—breast cancer	2.62e-05	8.67e-05	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Epirubicin—breast cancer	2.61e-05	8.66e-05	CcSEcCtD
Ketorolac—Fatigue—Epirubicin—breast cancer	2.61e-05	8.65e-05	CcSEcCtD
Ketorolac—PTGS2—Disease—JAG2—breast cancer	2.6e-05	0.000346	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—IDH1—breast cancer	2.59e-05	0.000345	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GSTA1—breast cancer	2.59e-05	0.000345	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—breast cancer	2.59e-05	0.000344	CbGpPWpGaD
Ketorolac—Pain—Epirubicin—breast cancer	2.59e-05	8.58e-05	CcSEcCtD
Ketorolac—Constipation—Epirubicin—breast cancer	2.59e-05	8.58e-05	CcSEcCtD
Ketorolac—Nausea—Capecitabine—breast cancer	2.58e-05	8.55e-05	CcSEcCtD
Ketorolac—PTGS1—Metabolism—HPGDS—breast cancer	2.58e-05	0.000343	CbGpPWpGaD
Ketorolac—Urticaria—Methotrexate—breast cancer	2.57e-05	8.51e-05	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—breast cancer	2.57e-05	0.000342	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—HBA1—breast cancer	2.56e-05	0.000341	CbGpPWpGaD
Ketorolac—PTGS2—Disease—WNT1—breast cancer	2.56e-05	0.000341	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—NAT2—breast cancer	2.56e-05	0.000341	CbGpPWpGaD
Ketorolac—Abdominal pain—Methotrexate—breast cancer	2.56e-05	8.47e-05	CcSEcCtD
Ketorolac—Body temperature increased—Methotrexate—breast cancer	2.56e-05	8.47e-05	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.55e-05	8.45e-05	CcSEcCtD
Ketorolac—PTGS2—Disease—SLC2A2—breast cancer	2.54e-05	0.000339	CbGpPWpGaD
Ketorolac—Insomnia—Doxorubicin—breast cancer	2.53e-05	8.39e-05	CcSEcCtD
Ketorolac—Paraesthesia—Doxorubicin—breast cancer	2.51e-05	8.33e-05	CcSEcCtD
Ketorolac—PTGS1—Metabolism—ACHE—breast cancer	2.5e-05	0.000333	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GSTT1—breast cancer	2.5e-05	0.000333	CbGpPWpGaD
Ketorolac—Dyspnoea—Doxorubicin—breast cancer	2.5e-05	8.27e-05	CcSEcCtD
Ketorolac—Feeling abnormal—Epirubicin—breast cancer	2.49e-05	8.26e-05	CcSEcCtD
Ketorolac—PTGS2—Disease—MTR—breast cancer	2.49e-05	0.000332	CbGpPWpGaD
Ketorolac—Somnolence—Doxorubicin—breast cancer	2.49e-05	8.25e-05	CcSEcCtD
Ketorolac—Gastrointestinal pain—Epirubicin—breast cancer	2.47e-05	8.2e-05	CcSEcCtD
Ketorolac—Dyspepsia—Doxorubicin—breast cancer	2.46e-05	8.17e-05	CcSEcCtD
Ketorolac—Decreased appetite—Doxorubicin—breast cancer	2.43e-05	8.07e-05	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Doxorubicin—breast cancer	2.42e-05	8.01e-05	CcSEcCtD
Ketorolac—Fatigue—Doxorubicin—breast cancer	2.41e-05	8e-05	CcSEcCtD
Ketorolac—Urticaria—Epirubicin—breast cancer	2.4e-05	7.97e-05	CcSEcCtD
Ketorolac—Constipation—Doxorubicin—breast cancer	2.39e-05	7.94e-05	CcSEcCtD
Ketorolac—Pain—Doxorubicin—breast cancer	2.39e-05	7.94e-05	CcSEcCtD
Ketorolac—Abdominal pain—Epirubicin—breast cancer	2.39e-05	7.93e-05	CcSEcCtD
Ketorolac—Body temperature increased—Epirubicin—breast cancer	2.39e-05	7.93e-05	CcSEcCtD
Ketorolac—Hypersensitivity—Methotrexate—breast cancer	2.38e-05	7.9e-05	CcSEcCtD
Ketorolac—PTGS1—Metabolism—CYP17A1—breast cancer	2.37e-05	0.000315	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	2.36e-05	0.000314	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ENO1—breast cancer	2.34e-05	0.000312	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	2.34e-05	0.000311	CbGpPWpGaD
Ketorolac—Asthenia—Methotrexate—breast cancer	2.32e-05	7.69e-05	CcSEcCtD
Ketorolac—PTGS2—Disease—HSPA1B—breast cancer	2.32e-05	0.000308	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—CAV1—breast cancer	2.32e-05	0.000308	CbGpPWpGaD
Ketorolac—Feeling abnormal—Doxorubicin—breast cancer	2.31e-05	7.65e-05	CcSEcCtD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—ALB—breast cancer	2.31e-05	0.000307	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CYP2D6—breast cancer	2.3e-05	0.000306	CbGpPWpGaD
Ketorolac—Gastrointestinal pain—Doxorubicin—breast cancer	2.29e-05	7.59e-05	CcSEcCtD
Ketorolac—Pruritus—Methotrexate—breast cancer	2.29e-05	7.58e-05	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	2.28e-05	0.000304	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—NCOA2—breast cancer	2.26e-05	0.0003	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—DPYD—breast cancer	2.25e-05	0.000299	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—MED12—breast cancer	2.25e-05	0.000299	CbGpPWpGaD
Ketorolac—Hypersensitivity—Epirubicin—breast cancer	2.23e-05	7.39e-05	CcSEcCtD
Ketorolac—Urticaria—Doxorubicin—breast cancer	2.22e-05	7.37e-05	CcSEcCtD
Ketorolac—PTGS2—Disease—ENO1—breast cancer	2.22e-05	0.000296	CbGpPWpGaD
Ketorolac—Body temperature increased—Doxorubicin—breast cancer	2.21e-05	7.34e-05	CcSEcCtD
Ketorolac—Abdominal pain—Doxorubicin—breast cancer	2.21e-05	7.34e-05	CcSEcCtD
Ketorolac—Diarrhoea—Methotrexate—breast cancer	2.21e-05	7.33e-05	CcSEcCtD
Ketorolac—PTGS2—Metabolism—ALDOA—breast cancer	2.21e-05	0.000294	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—FASN—breast cancer	2.19e-05	0.000291	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—BCHE—breast cancer	2.18e-05	0.00029	CbGpPWpGaD
Ketorolac—Asthenia—Epirubicin—breast cancer	2.17e-05	7.2e-05	CcSEcCtD
Ketorolac—PTGS1—Metabolism—SLC5A5—breast cancer	2.15e-05	0.000286	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—NCOA3—breast cancer	2.15e-05	0.000286	CbGpPWpGaD
Ketorolac—Pruritus—Epirubicin—breast cancer	2.14e-05	7.1e-05	CcSEcCtD
Ketorolac—Dizziness—Methotrexate—breast cancer	2.14e-05	7.09e-05	CcSEcCtD
Ketorolac—PTGS2—Metabolism—SLC2A2—breast cancer	2.13e-05	0.000283	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	2.11e-05	0.000281	CbGpPWpGaD
Ketorolac—PTGS2—Disease—FGF3—breast cancer	2.1e-05	0.00028	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CPT1A—breast cancer	2.09e-05	0.000278	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—MTR—breast cancer	2.09e-05	0.000278	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ABCG2—breast cancer	2.09e-05	0.000278	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—NQO1—breast cancer	2.08e-05	0.000277	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—SLC2A1—breast cancer	2.08e-05	0.000277	CbGpPWpGaD
Ketorolac—PTGS2—Disease—FASN—breast cancer	2.07e-05	0.000276	CbGpPWpGaD
Ketorolac—PTGS2—Disease—JAG1—breast cancer	2.07e-05	0.000276	CbGpPWpGaD
Ketorolac—Diarrhoea—Epirubicin—breast cancer	2.07e-05	6.86e-05	CcSEcCtD
Ketorolac—PTGS2—Disease—PARP1—breast cancer	2.07e-05	0.000275	CbGpPWpGaD
Ketorolac—Hypersensitivity—Doxorubicin—breast cancer	2.06e-05	6.84e-05	CcSEcCtD
Ketorolac—Vomiting—Methotrexate—breast cancer	2.06e-05	6.81e-05	CcSEcCtD
Ketorolac—PTGS2—Metabolism—HPGDS—breast cancer	2.05e-05	0.000272	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CALCA—breast cancer	2.04e-05	0.000271	CbGpPWpGaD
Ketorolac—Rash—Methotrexate—breast cancer	2.04e-05	6.76e-05	CcSEcCtD
Ketorolac—Dermatitis—Methotrexate—breast cancer	2.04e-05	6.75e-05	CcSEcCtD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	2.04e-05	0.000271	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—HBA1—breast cancer	2.03e-05	0.000271	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CYP3A4—breast cancer	2.03e-05	0.00027	CbGpPWpGaD
Ketorolac—Headache—Methotrexate—breast cancer	2.03e-05	6.71e-05	CcSEcCtD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	2.02e-05	0.000268	CbGpPWpGaD
Ketorolac—PTGS2—Disease—RPS6—breast cancer	2.02e-05	0.000268	CbGpPWpGaD
Ketorolac—Asthenia—Doxorubicin—breast cancer	2.01e-05	6.66e-05	CcSEcCtD
Ketorolac—Dizziness—Epirubicin—breast cancer	2e-05	6.63e-05	CcSEcCtD
Ketorolac—PTGS2—Disease—FGF4—breast cancer	2e-05	0.000266	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CYP1B1—breast cancer	1.99e-05	0.000265	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CXCR4—breast cancer	1.99e-05	0.000265	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ACHE—breast cancer	1.99e-05	0.000264	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GSTT1—breast cancer	1.99e-05	0.000264	CbGpPWpGaD
Ketorolac—Pruritus—Doxorubicin—breast cancer	1.98e-05	6.57e-05	CcSEcCtD
Ketorolac—PTGS2—Disease—SLC2A1—breast cancer	1.97e-05	0.000262	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—HSP90AA1—breast cancer	1.95e-05	0.00026	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	1.93e-05	0.000256	CbGpPWpGaD
Ketorolac—Vomiting—Epirubicin—breast cancer	1.92e-05	6.38e-05	CcSEcCtD
Ketorolac—PTGS2—Disease—TCF7L2—breast cancer	1.92e-05	0.000256	CbGpPWpGaD
Ketorolac—Nausea—Methotrexate—breast cancer	1.92e-05	6.37e-05	CcSEcCtD
Ketorolac—Diarrhoea—Doxorubicin—breast cancer	1.92e-05	6.35e-05	CcSEcCtD
Ketorolac—Rash—Epirubicin—breast cancer	1.91e-05	6.32e-05	CcSEcCtD
Ketorolac—Dermatitis—Epirubicin—breast cancer	1.91e-05	6.32e-05	CcSEcCtD
Ketorolac—PTGS1—Metabolism—NCOA1—breast cancer	1.9e-05	0.000253	CbGpPWpGaD
Ketorolac—Headache—Epirubicin—breast cancer	1.9e-05	6.28e-05	CcSEcCtD
Ketorolac—PTGS2—Metabolism—CYP17A1—breast cancer	1.88e-05	0.00025	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CYP19A1—breast cancer	1.87e-05	0.000249	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—STK11—breast cancer	1.87e-05	0.000249	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PTGS1—breast cancer	1.86e-05	0.000248	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ENO1—breast cancer	1.86e-05	0.000248	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	1.85e-05	0.000247	CbGpPWpGaD
Ketorolac—PTGS2—Disease—HSP90AA1—breast cancer	1.85e-05	0.000246	CbGpPWpGaD
Ketorolac—Dizziness—Doxorubicin—breast cancer	1.85e-05	6.14e-05	CcSEcCtD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—ALB—breast cancer	1.83e-05	0.000243	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CYP2D6—breast cancer	1.82e-05	0.000243	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PRL—breast cancer	1.8e-05	0.00024	CbGpPWpGaD
Ketorolac—Nausea—Epirubicin—breast cancer	1.8e-05	5.96e-05	CcSEcCtD
Ketorolac—PTGS2—Metabolism—NCOA2—breast cancer	1.79e-05	0.000238	CbGpPWpGaD
Ketorolac—Vomiting—Doxorubicin—breast cancer	1.78e-05	5.9e-05	CcSEcCtD
Ketorolac—PTGS2—Disease—ADAM10—breast cancer	1.78e-05	0.000236	CbGpPWpGaD
Ketorolac—Rash—Doxorubicin—breast cancer	1.77e-05	5.85e-05	CcSEcCtD
Ketorolac—Dermatitis—Doxorubicin—breast cancer	1.76e-05	5.85e-05	CcSEcCtD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.76e-05	0.000234	CbGpPWpGaD
Ketorolac—Headache—Doxorubicin—breast cancer	1.75e-05	5.81e-05	CcSEcCtD
Ketorolac—PTGS1—Metabolism—COMT—breast cancer	1.74e-05	0.000232	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—FASN—breast cancer	1.74e-05	0.000231	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GSTP1—breast cancer	1.73e-05	0.000231	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—BCHE—breast cancer	1.73e-05	0.00023	CbGpPWpGaD
Ketorolac—PTGS2—Disease—FGF10—breast cancer	1.73e-05	0.00023	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—HMOX1—breast cancer	1.71e-05	0.000227	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—SLC5A5—breast cancer	1.71e-05	0.000227	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ITPR1—breast cancer	1.71e-05	0.000227	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PDGFA—breast cancer	1.67e-05	0.000222	CbGpPWpGaD
Ketorolac—Nausea—Doxorubicin—breast cancer	1.66e-05	5.51e-05	CcSEcCtD
Ketorolac—PTGS2—Metabolism—SLC2A1—breast cancer	1.65e-05	0.00022	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—NQO1—breast cancer	1.65e-05	0.00022	CbGpPWpGaD
Ketorolac—PTGS2—Disease—TGFBR2—breast cancer	1.64e-05	0.000219	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ABCB1—breast cancer	1.64e-05	0.000218	CbGpPWpGaD
Ketorolac—PTGS2—Disease—ITPR1—breast cancer	1.62e-05	0.000215	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.62e-05	0.000215	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—TYMS—breast cancer	1.61e-05	0.000214	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CYP3A4—breast cancer	1.61e-05	0.000214	CbGpPWpGaD
Ketorolac—PTGS2—Disease—STAT5A—breast cancer	1.61e-05	0.000214	CbGpPWpGaD
Ketorolac—PTGS2—Disease—ERBB4—breast cancer	1.61e-05	0.000214	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PLA2G4A—breast cancer	1.59e-05	0.000212	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GSTM1—breast cancer	1.59e-05	0.000212	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—NCOR1—breast cancer	1.59e-05	0.000212	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CYP1B1—breast cancer	1.58e-05	0.00021	CbGpPWpGaD
Ketorolac—PTGS2—Disease—SMAD4—breast cancer	1.56e-05	0.000207	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—HSP90AA1—breast cancer	1.55e-05	0.000206	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GPX1—breast cancer	1.53e-05	0.000203	CbGpPWpGaD
Ketorolac—PTGS2—Disease—HES1—breast cancer	1.52e-05	0.000202	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CYP1A1—breast cancer	1.51e-05	0.000201	CbGpPWpGaD
Ketorolac—PTGS2—Disease—NCOR1—breast cancer	1.51e-05	0.000201	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—NCOA1—breast cancer	1.51e-05	0.000201	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ERCC2—breast cancer	1.5e-05	0.000199	CbGpPWpGaD
Ketorolac—PTGS2—Disease—FGF1—breast cancer	1.49e-05	0.000199	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—STK11—breast cancer	1.49e-05	0.000198	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CYP19A1—breast cancer	1.49e-05	0.000198	CbGpPWpGaD
Ketorolac—PTGS2—Disease—NRG1—breast cancer	1.48e-05	0.000197	CbGpPWpGaD
Ketorolac—PTGS2—Disease—H2AFX—breast cancer	1.47e-05	0.000196	CbGpPWpGaD
Ketorolac—PTGS2—Disease—ERCC2—breast cancer	1.42e-05	0.000189	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—MTHFR—breast cancer	1.41e-05	0.000187	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.4e-05	0.000186	CbGpPWpGaD
Ketorolac—PTGS2—Disease—ERBB3—breast cancer	1.39e-05	0.000185	CbGpPWpGaD
Ketorolac—PTGS2—Disease—FGFR2—breast cancer	1.39e-05	0.000184	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—COMT—breast cancer	1.38e-05	0.000184	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GSTP1—breast cancer	1.38e-05	0.000183	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—HMOX1—breast cancer	1.36e-05	0.000181	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ITPR1—breast cancer	1.35e-05	0.00018	CbGpPWpGaD
Ketorolac—PTGS2—Disease—MTHFR—breast cancer	1.33e-05	0.000178	CbGpPWpGaD
Ketorolac—PTGS2—Disease—TERT—breast cancer	1.33e-05	0.000177	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ABCB1—breast cancer	1.3e-05	0.000173	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CAV1—breast cancer	1.3e-05	0.000173	CbGpPWpGaD
Ketorolac—PTGS2—Disease—FGFR1—breast cancer	1.29e-05	0.000172	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—TYMS—breast cancer	1.28e-05	0.00017	CbGpPWpGaD
Ketorolac—PTGS2—Disease—HIF1A—breast cancer	1.27e-05	0.000169	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PLA2G4A—breast cancer	1.26e-05	0.000168	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—NCOR1—breast cancer	1.26e-05	0.000168	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GSTM1—breast cancer	1.26e-05	0.000168	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.24e-05	0.000165	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CAV1—breast cancer	1.23e-05	0.000164	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GPX1—breast cancer	1.21e-05	0.000161	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CYP1A1—breast cancer	1.2e-05	0.00016	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ERCC2—breast cancer	1.19e-05	0.000158	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PIK3CG—breast cancer	1.18e-05	0.000157	CbGpPWpGaD
Ketorolac—PTGS2—Disease—NOS2—breast cancer	1.16e-05	0.000154	CbGpPWpGaD
Ketorolac—PTGS2—Disease—NOTCH1—breast cancer	1.15e-05	0.000153	CbGpPWpGaD
Ketorolac—PTGS2—Disease—KIT—breast cancer	1.12e-05	0.000149	CbGpPWpGaD
Ketorolac—PTGS2—Disease—APC—breast cancer	1.12e-05	0.000149	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—MTHFR—breast cancer	1.12e-05	0.000149	CbGpPWpGaD
Ketorolac—PTGS2—Disease—EGF—breast cancer	1.11e-05	0.000147	CbGpPWpGaD
Ketorolac—PTGS2—Disease—BRAF—breast cancer	1.05e-05	0.00014	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PIK3CD—breast cancer	1.04e-05	0.000138	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CAV1—breast cancer	1.03e-05	0.000137	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ALB—breast cancer	1.03e-05	0.000137	CbGpPWpGaD
Ketorolac—PTGS2—Disease—AKT2—breast cancer	1.03e-05	0.000137	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PIK3CD—breast cancer	9.86e-06	0.000131	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	9.85e-06	0.000131	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—NOS3—breast cancer	9.82e-06	0.000131	CbGpPWpGaD
Ketorolac—PTGS2—Disease—SERPINE1—breast cancer	9.75e-06	0.00013	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PIK3CG—breast cancer	9.39e-06	0.000125	CbGpPWpGaD
Ketorolac—PTGS2—Disease—NOS3—breast cancer	9.31e-06	0.000124	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PIK3CB—breast cancer	9.07e-06	0.000121	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PTGS2—breast cancer	8.98e-06	0.000119	CbGpPWpGaD
Ketorolac—PTGS2—Disease—MDM2—breast cancer	8.83e-06	0.000117	CbGpPWpGaD
Ketorolac—PTGS2—Disease—RAF1—breast cancer	8.8e-06	0.000117	CbGpPWpGaD
Ketorolac—PTGS2—Disease—ERBB2—breast cancer	8.71e-06	0.000116	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PIK3CB—breast cancer	8.59e-06	0.000114	CbGpPWpGaD
Ketorolac—PTGS2—Disease—MTOR—breast cancer	8.59e-06	0.000114	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CD4—breast cancer	8.58e-06	0.000114	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PIK3CD—breast cancer	8.26e-06	0.00011	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ALB—breast cancer	8.15e-06	0.000108	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CDKN1B—breast cancer	8.06e-06	0.000107	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PTEN—breast cancer	7.83e-06	0.000104	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—NOS3—breast cancer	7.8e-06	0.000104	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CTNNB1—breast cancer	7.62e-06	0.000101	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CDKN1A—breast cancer	7.44e-06	9.9e-05	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PTEN—breast cancer	7.43e-06	9.88e-05	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PIK3CB—breast cancer	7.2e-06	9.57e-05	CbGpPWpGaD
Ketorolac—PTGS2—Disease—SRC—breast cancer	6.89e-06	9.16e-05	CbGpPWpGaD
Ketorolac—PTGS2—Disease—STAT3—breast cancer	6.64e-06	8.83e-05	CbGpPWpGaD
Ketorolac—PTGS2—Disease—MAPK3—breast cancer	6.34e-06	8.44e-05	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PTEN—breast cancer	6.22e-06	8.27e-05	CbGpPWpGaD
Ketorolac—PTGS2—Disease—MYC—breast cancer	6.17e-06	8.21e-05	CbGpPWpGaD
Ketorolac—PTGS2—Disease—TGFB1—breast cancer	6.16e-06	8.19e-05	CbGpPWpGaD
Ketorolac—PTGS2—Disease—EGFR—breast cancer	6.04e-06	8.03e-05	CbGpPWpGaD
Ketorolac—PTGS2—Disease—KRAS—breast cancer	5.7e-06	7.59e-05	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PIK3CA—breast cancer	5.53e-06	7.35e-05	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PIK3CA—breast cancer	5.24e-06	6.97e-05	CbGpPWpGaD
Ketorolac—PTGS2—Disease—HRAS—breast cancer	4.85e-06	6.45e-05	CbGpPWpGaD
Ketorolac—PTGS2—Disease—IL6—breast cancer	4.64e-06	6.17e-05	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—AKT1—breast cancer	4.51e-06	6.01e-05	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PIK3CA—breast cancer	4.39e-06	5.84e-05	CbGpPWpGaD
Ketorolac—PTGS2—Disease—AKT1—breast cancer	4.28e-06	5.69e-05	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—AKT1—breast cancer	3.58e-06	4.77e-05	CbGpPWpGaD
